More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...
Active ingredient: Rufinamide 200 mg, 400 mg; scored tabs. Indication: Adjunctive treatment of seizures in Lennox-Gastaut syndrome (LGS). Pharmacology: LGS is a seizure disorder characterized by ...
A seizure occurs when there is abnormal electrical activity in the brain. There are different types of seizures depending on where and how much brain activity is affected. If someone is seizing make ...
More than 3.4 million people in the US and 65 million people worldwide have epilepsy, a neurological disorder that affects the nervous system and causes seizures. One in 26 people will develop ...
ALBANY, N.Y. (NEWS10) – Epilepsy is the fourth most common neurological disorder in the United States and can impact women and men. An estimated 3.4 million people in the U.S. have epilepsy, but there ...
More than 3.4 million people in the US and 65 million people worldwide have epilepsy, a neurological disorder that affects the nervous system and causes seizures. One in 26 people will develop ...
Researchers at the University of Southern California (USC) have developed an AI system that promises to improve the detection of rare and complex cases of epilepsy. Epilepsy is a condition that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results